Stockreport

Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026 [Yahoo! Finance]

Molecular Partners AG - American Depositary Shares  (MOLN) 
PDF Dosimetry data highlight Radio-DARPins as vector for precise delivery of potent alpha-emitting isotopes to tumors MP0712 Phase 1/2a study open in U.S. with initial cl [Read more]